common.study.topics.clinical

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

common.study.values.description

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Investigators will recruit 250 subjects; Group A will consist of 100 prediabetic patients with an A1c of 5.7%-6.4%. Group B will consist of 100 patients with uncontrolled T2D defined as either a) an A1c of 6.5%-7.9% without diabetes medications or b) an A1c a?Y 8.0% with or without diabetes medications. Group C will include 50 participants without T2D or known cardiovascular disease to serve as control comparisons.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

common.study.methods.no-methods

participant.views.study.view.additional

participant.views.study.view.scientific-title

Arsenic Exposure, Disordered Glucose Homeostasis and Atherosclerosis Protocol

common.study.values.clinical-trial-id

NCT02759289

participant.views.study.view.id

6dBXQa